Exploring Platelet-Rich Plasma in Dermatology

In her session, “Platelet-Rich Plasma in Dermatology,” presented at Spring Dermatology Week 2024, Dr Amelia Hausauer illuminated the landscape of platelet-rich plasma (PRP) in dermatology.

Amelia K. Hausauer, MD, is the director of dermatology and head of aesthetic medicine at Aesthetx Plastic Surgery & Dermatology in Silicon Valley, CA. With a focus on technical and clinical nuances, Dr Hausauer reviewed the applications of PRP, ranging from hair restoration to scar treatment and rejuvenation. She touched upon PRP therapy, shedding light on key concepts contributing to its success while navigating gaps and controversies in the existing literature.

Delving into the essence of PRP, Dr Hausauer emphasized its autologous nature, characterized by a high platelet count and small plasma volume, essential for harnessing its regenerative potential. Highlighting the significance of US Food and Drug Administration-cleared devices, she underscored the complexities associated with PRP preparation and emphasized the pivotal role of technical proficiency and patient-specific considerations in achieving favorable outcomes.

Technical considerations took center stage as Dr Hausauer dissected the intricacies of PRP preparation, ranging from cell concentration and activation to centrifugation techniques. Attendees gained insights into optimizing PRP composition and preparation methods, crucial for tailoring treatment plans to individual patient needs.

Navigating through clinical applications, Dr Hausauer illuminated the efficacy of PRP in androgenetic alopecia, scar treatment, and skin rejuvenation. Attendees were presented with compelling evidence demonstrating the potential of PRP to stimulate hair growth, improve wound healing, and enhance skin texture and elasticity.

Addressing candidate selection and treatment protocols, Dr Hausauer underscored the importance of patient demographics, disease severity, and combination therapies in optimizing treatment outcomes. Attendees were equipped with evidence-based regimens for initiating and maintaining PRP therapy across various dermatologic indications.

As discussions traversed second-generation products like platelet-rich fibrin, Dr Hausauer outlined the biologic mechanisms and clinical implications of these advanced formulations, signaling a promising frontier in PRP therapy.

For more meeting coverage, visit the Spring Dermatology Week 2024 newsroom.

Maximize your experience by adding up to 90-days of on-demand access. Find the package that works for you. Upgrade here.

Reference
Hausauer AK. Platelet-rich plasma in dermatology. Presented at: Dermatology Week; May 8–11, 2024; Virtual.